Ann: Extension for Voluntary Suspension, page-253

Fair enough, though just to clarify once again I have followed ADO for years (and held) so not following you, just confused on the difference in outlooks at the time.

Do I believe WP misled RIs in recent times?, yes I do, imo, right to the end, overpromised and under delivered, that the 30 cent CR turned out to be a failure and the ‘shock’ of a second CR shortly after showed some serious ‘missed’ issues, imo.
Would they have been aware after the 30 cent CR a further one would be necessary?

Did the company try to run before it could walk?, increased spending that might have been dependent on ‘expected’ revenues a issue?, too many potential products in the pipeline?,

We may never know the answer to those questions.

WP said quite a while ago ‘successful IP does not guarantee successful commercialisation’ so seemly had a grasp on the complexities of achieving that.

Lack of ‘take up’ has been a issue for years, Eg; CardioCel centre countdown, all for nought, so some awareness must have been present.

Tough gig, you betcha, though not helped when time after time it was stressed that everything was well in hand instead of a more cautious outlook and ‘then’ over delivering, be a lot better sentiment now, imo.

Anybody challenging those WP outlooks was ‘lynched’ at the time and accused of running the stock down ..... and now?

Ancient history, IF WP can ensure funds of 30 mill plus then things might work out fine, though share dilution, significant losses of capital has cost RIs dearly.

It continues to amaze me when comparing this stock to RAP and BIT and the sp Admedus is at compared to those two, so if things go right you could expect Admedus to be right up there, as suziki totally believes, though ‘getting’ it right still a work in progress.